Asbury R F, Rosenthal S N, Descalzi M E, Ratcliffe R L, Arseneau J C
Cancer. 1980 May 15;45(10):2670-4. doi: 10.1002/1097-0142(19800515)45:10<2670::aid-cncr2820451031>3.0.co;2-l.
A case of fulminant hepatic failure leading to death in a patient receiving DTIC for metastatic melanoma is presented. Autopsy revealed widespread centrilobular necrosis secondary to a veno-occlusive process. There was no evidence of a similar process in other organs, and common causes of similar pathology were ruled out. It is likely that in this patient the hepatic failure was due to DTIC alone. Similar cases have been reported in patients receiving other chemotherapeutic agents. Physicians using these drugs should be aware of this side-effect of therapy, since it is often fatal.
本文报告了一例接受达卡巴嗪治疗转移性黑色素瘤的患者发生暴发性肝衰竭并导致死亡的病例。尸检显示,静脉闭塞性病变继发广泛的小叶中心坏死。其他器官未发现类似病变,排除了类似病理改变的常见病因。该患者的肝衰竭很可能仅由达卡巴嗪所致。接受其他化疗药物治疗的患者也有类似病例报告。使用这些药物的医生应了解这种治疗副作用,因为它往往是致命的。